个人简介
Dr. ZHENG Yu, MD, attending of the SRRSH Department of Medical Oncology. Dr. Zheng graduated from Zhejiang University in 1999 and started working since then. He specializes in the diagnosis and therapy of lung cancer, digestive tract tumors and cancers of unknown primary and is experienced in radiofrequency ablation of primary or metastatic tumors of the liver. He has been responsible for or participated in multiple national and provincial medical research projects and published dozens of papers in his field.
In June 2004, Dr. Zheng participated in the GCP training of the State Food and Drug Administration (SFDA) and obtained the qualification certificate. He has participated in more than 40 international and domestic multicenter clinical trials. His multiple clinical research results have been included in international and domestic cancer treatment guidelines.
学术任职
Member of the Integrative Rehabilitation Professional Committee for Gastric Tumors of the Chinese Anti-Cancer Association
Member of the Colorectal Cancer Professional Committee of the Zhejiang Medical Association
Vice Chairman of the Tumor Physical Therapy Professional Committee of the Zhejiang Anti-Cancer Association
Member of the Gastric Cancer Professional Committee of the Zhejiang Anti-Cancer Association
相关专家
-
WANG Xian Medical OncologyProfessor/Senior ConsultantPrevention, diagnosis and differential diagnosis of various malignant tumors as well as the chemotherapy and molecular targeted drug therapy of malignant tumors;preoperative neoadjuvant therapy of breast cancer, postoperative adjuvant therapy and comprehensive treatment of advanced breast cancer; clinical trials of novel antitumor drugs.
-
PAN Hongming Medical OncologySenior Consultant, professorDiagnosis, chemotherapy, targeting, immunization and radiofrequency ablation of various malignant tumors, and clinical trials of anti-tumor drugs.
-
FANG Yong Medical OncologySenior ConsultantMinimally invasive ablation of lung tumor; tumor biological immunotherapy; comprehensive treatment.
-
LI Da Medical OncologySenior ConsultantComprehensive treatment of lung cancer and digestive tract tumors, minimally invasive treatment of solid tumors and the treatment of drug toxicity and side effects, and drug resistance mechanism and delivery in vivo.
-
LOU Haizhou Medical OncologySenior ConsultantDiagnosis of various solid tumors, chemotherapy, targeted therapy, immunotherapy and integrated treatment of traditional Chinese and Western medicine, especially the comprehensive treatment of lung cancer and digestive tract tumors.
-
PAN Qin Medical OncologyConsultantStandardized diagnosis and treatment of tumor nutrition; diagnosis and treatment of malignant lymphoma; palliative care.
-
LOU Fang Medical OncologyConsultantDiagnosis of various solid tumors and the formulation of comprehensive treatment plans, especially the diagnosis, comprehensive treatment and clinical research of new drugs for malignant tumors such as melanoma, liver cancer, ovarian cancer and cervical cancer.
-
JIN Wei Medical OncologyConsultantA variety of common tumor diagnosis, chemotherapy, targeted therapy, immunotherapy and other individualized comprehensive treatment and minimally invasive radiofrequency therapy.
-
HU Hong Medical OncologyConsultantComprehensive diagnosis and treatment of common malignant tumors, tumor immunity and targeted therapy, tumor radiofrequency ablation, clinical research of new tumor drugs.
-
SHOU Jiawei Medical OncologyConsultantImmune and targeted therapy and drug resistance strategies for lung cancer; Tumor genetics and vaccines; Liver and gallbladder tumors; Tumor ablation techniques.
-
LU Haiqi Medical OncologyConsultantComprehensive treatment of common malignant tumors, with particular expertise in the diagnosis and precision treatment of breast, digestive system, and urinary system malignant tumors, as well as multiple primary tumors. She also specializes in research on drug resistance mechanisms and genetic screening for high-risk tumor populations.
-
ZHOU Xiaoyun Medical OncologyDeputy Chief PhysicianDiagnosis and treatment of ovarian cancer, lung cancer, gastric cancer, colon-rectal cancer, liver cancer, pancreatic cancer, breast cancer, especially the accurate treatment of ovary cancer, lung cancer and gastrointestinal tumors.
-
YOU Liangkun Medical OncologyConsultantTargeted therapy, immunotherapy, and chemotherapy for various solid tumors; comprehensive treatment for lung cancer; clinical research on lung cancer, pancreatic cancer, urinary system tumors, and nutritional therapy for tumors.
-
SHENG Jin Medical OncologyConsultantMolecular targeted therapy, chemotherapy, and immunotherapy for lung cancer, gastric cancer, colon cancer, pancreatic cancer, and malignant tumors with unknown primary focus; comprehensive treatment of solid tumors and case management, palliative care; molecular gene analysis and precision treatment of lung cancer and digestive tract tumors.
-
GONG Liu Medical OncologyConsultantLung cancer, neuroendocrine neoplasm, gastric cancer, colorectal cancer, hepatocarcinoma, pancreatic cancer, carcinoma of the bile duct and gynecological malignancies, especially the accurate treatment of NSCLC, SCLC and neuroendocrine neoplasm.
-
YAO Junlin Medical OncologyConsultantIntegrated management of malignant gastrointestinal tumors and breast cancer, including chemotherapy, targeted therapy, and immunotherapy for gastric cancer, colorectal cancer, liver cancer, cholangiocarcinoma, pancreatic cancer, esophageal cancer, and breast cancer; clinical research on novel drugs for advanced solid tumors.
-
ZHAI Chongya Medical OncologyConsultantComprehensive diagnosis and treatment of various solid tumors such as digestive tract malignant tumors and lung malignant tumors, as well as handling of adverse reactions to drugs.
-
WU Zhuoxuan Medical OncologyConsultantPrecision treatment of lung cancer and gastrointestinal tract tumors; holistic management of brain metastases; clinical trials of new drugs for solid tumors.
-
LI Hongsen Medical OncologyConsultantIndividualized treatment of malignant tumors of the respiratory and digestive tracts. Clinical research of new anti-tumor drugs.